Genetic Profiling of Breast Cancers

Aiming to achieve personalised medicine

Genetic profiling has revolutionised our understanding of breast cancer, but despite offering great promise to better predict outcomes and optimise treatment for individual patients, a decade on, our ability to individualise therapy based on robust prognostic and predictive factors remains limited. Professor Jorge Reis-Filho from the Institute of Cancer Research, London, UK, one of the authors talks to us about his findings in the Lancet series.

http://www.lancet.com